PEG IFN-alpha-2b effective against HBeAg+ hepatitis BHepatitis-B, treatmentLamivudine, therapeutic usePeginterferon-alfa-2b, therapeutic use
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006;44:728--35.Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic...
PEG IFN-alpha-2b plus ribavirin worth its cost in chronic hepatitis CCost-utilityHepatitis-C, treatmentInterferon-alpha-2b, therapeutic usePEG-interferon-alpha-2b, therapeutic useRibavirin, therapeutic useInpharma Weekly -doi:10.2165/00128413-200313790-00013None...
Peginterferon-alfa-2b, therapeutic useRegulatory-processRibavirin, therapeutic useNA;Inpharma weekly
High incidence of depression and sleep disturbances associated with PegIFN-alpha-2b/ribivirin therapy for hepatitis C in routine clinical practiceThe American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked ...
Insulin resistance (IR) - an important prognostic factor reducing the effectiveness of the antiviral therapy in patients with chronic hepatitis C. Using of metformin as a drug which normalize the level of insulin resistance in CHC patients, treated with Peg- IFNalpha-2b+ribavirin increases its ...
[520] PREDICTION OF SUSTAINED ALT NORMALIZATION BY VIRAL LOAD DURING PEG-IFN ALPHA-2b TREATMENT FOR HBeAg-POSITIVE CHRONIC HEPATITIS Bdoi:10.1016/S0168-8278(07)62118-7M.J. ter Bora and B.E. Hansen and G. Bigot and B.L. Haagmans and H.L. Tanssen...
An abstract of the article "High Incidence of Depression and Sleep Disturbances Associated with PegIFN-Alpha-2b/Ribivirin Therapy for Hepatitis C in Routine Clinical Practice," by David Finkelman is presented.doi:10.1111/j.1572-0241.2003.07986.xFinkelman...
Nonalcoholic steatohepatitis, in which fatty change and inflammation of the liver occur in the absence of excess alcohol intake, is increasingly recognized in obese children. Although fibrosis is common in pediatric nonalcoholic steatohepatitis, cirrhosis has been reported rarely. The two boys reported ...
We propose a method to predict final clinical outcome for 24 HIV鈥揌CV - coinfected patients with the help of a mathematical model based on the first two weeks of PEG-IFN therapy. Applying a pharmacokinetic-pharmacodynamic (PKPD) approach, together with mixture models, to the adapted model of...